Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
P62258
UPID:
1433E_HUMAN
Alternative names:
-
Alternative UPACC:
P62258; B3KY71; D3DTH5; P29360; P42655; Q4VJB6; Q53XZ5; Q63631; Q7M4R4
Background:
The 14-3-3 protein epsilon plays a pivotal role in cellular processes by acting as an adapter protein. It regulates a wide array of signaling pathways through its ability to bind a multitude of partners, recognizing phosphoserine or phosphothreonine motifs. This interaction typically alters the activity of the binding partner, enhancing processes such as the nuclear export of phosphorylated protein HSF1 to the cytoplasm.
Therapeutic significance:
Understanding the role of 14-3-3 protein epsilon could open doors to potential therapeutic strategies. Its involvement in key cellular mechanisms underscores its potential as a target for drug discovery, aiming to modulate its interaction with various signaling pathways for therapeutic benefits.